ORPHELIA Pharma announces Orphan Drug Designation granted by FDA for temozolomide in the treatment of neuroblastoma UncategorizedBy Charlotte Maddalena10 December 2019
Newsletter november 2019 UncategorizedBy Charlotte Maddalena4 December 2019It has been a busy year for our Endowment Fund and Corporate Foundation!